Критерии оценки качества медицинской помощи

N	Критерии качества	Оценка выполнения
1.	Выполнено измерение гликемии не реже 6 раз в 24 часа ежедневно	Да/Нет
2.	Выполнено исследование уровня гликированного гемоглобина	Да/Нет
3.	Выполнен анализ биохимический общетерапевтический (общий холестерин, липопротеины низкой плотности, триглицериды)	Да/Нет
4.	Выполнено измерение артериального давления	Да/Нет
5.	Выполнено исследование уровня тиреотропного гормона, свободного тироксина, антител к тиреопероксидазе и антител к тиреоглобулину у пациентов при диагностике диабета или при отсутствии данных результатов за последние два года	Да/Нет
6.	Выполнено исследование уровня антител к тканевой трансглутаминазе или/и антител к эндомизию (IgA или IgG при дефиците IgA) при диагностике диабета или при длительности диабета 2 - 5 лет	Да/Нет
7.	Выполнено исследование уровня альбумина в моче и креатинина в плазме крови с оценкой соотношения альбумин/креатинин альбуминурию у пациентов, начиная с возраста 11 лет, при длительности заболевания более 2 - 5 лет	Да/Нет
8.	Выполнена консультация и прием врача-офтальмолога у пациентов, начиная с возраста 11 лет, при длительности заболевания более 2 - 5 лет	Да/Нет
9.	Выполнена консультация и осмотр врача-невролога у пациентов, начиная с возраста 11 лет, при длительности заболевания более 2 - 5 лет	Да/Нет
10.	Выполнена консультация медицинского психолога пациента и/или родителя.	Да/Нет
11.	Выполнена заместительная интенсифицированная и/или помповая инсулинотерапия (в зависимости от медицинских показаний)	Да/Нет
12.	Проведено обучение в школе диабета по структурированной программе	Да/Нет

Список литературы

1. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association/R.A. Insel [et al.]//Diabetes Care. - 2015. - Vol. 38. - N 10. - P. 1964 - 1974.

2. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children/A.G. Ziegler [et al.]//JAMA. - 2013. - Vol. 309. - N 23. - P. 2473.

3. Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013 - 2016)/A.Y. Mayorov [и др.]//Diabetes mellitus. - 2019. - T. 21. - N 6. - C. 444 - 454.

4. Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013 - 2016)/D.V. Lipatov [и др.]//Diabetes mellitus. - 2018. - T. 21. - N 4. - C. 230 - 240.

5. Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013 - 2016)/G.R. Galstyan [и др.]//Diabetes mellitus. - 2018. - T. 21. - N 3. - C. 170 - 177.

6. Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013 - 2016)/M.S. Shamkhalova [и др.]//Diabetes mellitus. - 2018. - T. 21. - N 3. - C. 160 - 169.

7. Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013 - 2016/I.I. Dedov [и др.]//Diabetes mellitus. - 2018. - T. 20. - N 6. - C. 392 - 402.

8. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017/I.I. Dedov [и др.]//Diabetes mellitus. - 2018. - T. 21. - N 3. - C. 144 - 159.

9. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents/E.J. Mayer-Davis [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 7 - 19.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018/American Diabetes Association//Diabetes Care. - 2018. - Vol. 41. - N Supplement 1. - P. S13 - S27.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation/World Health Organization, International Diabetes Federation. - 2006.

12. Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review/R.A. Watkins [et al.]//Translational Research: The Journal of Laboratory and Clinical Medicine. - 2014. - Vol. 164. - N 2. - P. 110 - 121.

13. Etiological Approach to Characterization of Diabetes Type: The SEARCH for Diabetes in Youth Study/D. Dabelea [et al.]//Diabetes Care. - 2011. - Vol. 34. - N 7. - P. 1628 - 1633.

14. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth/P. Zeitler [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 28 - 46.

15. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality/Writing Group for the DCCT/EDIC Research Group [et al.]//JAMA. - 2015. - Vol. 313. - N 1. - P. 45 - 53.

16. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort/Writing Team for the DCCT/EDIC Research Group [et al.]//JAMA ophthalmology. - 2016. - Vol. 134. - N 2. - P. 137 - 145.

17. Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012/B. Karges [et al.]//PLoS medicine. - 2014. - Vol. 11. - N 10. - P. e1001742.

18. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes/L.A. DiMeglio [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 105 - 114.

19. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes/A. Fritsche [et al.]//Annals of Internal Medicine. - 2001. - Vol. 134. - N 9 Pt 1. - P. 729 - 736.

20. Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria/A. Schwandt [et al.]//Diabetes/Metabolism Research and Reviews. - 2017. - Vol. 33. - N 7.

21. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control/O.J. Driskell [et al.]//Diabetes Care. - 2014. - Vol. 37. - N 10. - P. 2731 - 2737.

22. A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus/M. Liu [et al.]//BMC endocrine disorders. - 2016. - Vol. 16. - N 1. - P. 67.

23. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus/E. Schober [et al.]//Journal of pediatric endocrinology & metabolism: JPEM. - 2002. - Vol. 15. - N 4. - P. 369 - 376.

24. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes/T. Danne [et al.]//Diabetes Care. - 2005. - Vol. 28. - N 9. - P. 2100 - 2105.

25. Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes/A. Philotheou [et al.]//Diabetes Technology & Therapeutics. - 2011. - Vol. 13. - N 3. - P. 327 - 334.

26. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents/J.H. Holcombe [et al.]//Clinical Therapeutics. - 2002. - Vol. 24. - N 4. - P. 629 - 638.

27. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus/S. Tupola [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. - 2001. - Vol. 18. - N 8. - P. 654 - 658.

28. Effectiveness of postprandial Humalog in toddlers with diabetes/K.S. Rutledge [et al.]//Pediatrics. - 1997. - Vol. 100. - N 6. - P. 968 - 972.

29. Insulin Lispro Lowers Postprandial Glucose in Prepubertal Children With Diabetes/L.C. Deeb [et al.]//PEDIATRICS. - 2001. - Vol. 108. - N 5. - P. 1175 - 1179.

30. Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial/T. Battelino [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - N 7. - P. 1263 - 1270.

31. Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes/B. Predieri [и др.]//Frontiers in Endocrinology. - 2018. - T. 9. - C. 462.

32. The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials/N. Thalange [et al.]//Pediatric Diabetes. - 2019. - Vol. 20. - N 3. - P. 314 - 320.

33. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes: IDeg effective and safe in pediatric T1D/N. Thalange [et al.]//Pediatric Diabetes. - 2015. - Vol. 16. - N 3. - P. 164 - 176.

34. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes/T. Danne [et al.]//Diabetes Care. - 2003. - Vol. 26. - N 11. - P. 3087 - 3092.

35. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes/K.J. Robertson [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. - 2007. - Vol. 24. - N 1. - P. 27 - 34.

36. ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes/T. Danne [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 115 - 135.

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group//The Journal of Pediatrics. - 1994. - Vol. 125. - N 2. - P. 177 - 188.

38. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial/G. Musen [et al.]//Diabetes Care. - 2008. - Vol. 31. - N 10. - P. 1933 - 1938.

39. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)/N.H. White [et al.]//The Journal of Pediatrics. - 2001. - Vol. 139. - N 6. - P. 804 - 812.

40. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)/R. Pop-Busui [et al.]//Circulation. - 2009. - Vol. 119. - N 22. - P. 2886 - 2893.

41. Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis/K. [et al.]//Diabetes Therapy. - 2018. - Vol. 9. - N 3. - P. 891 - 917.

42. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin/H.P. Chase [et al.]//The Journal of Pediatrics. - 2003. - Vol. 143. - N 6. - P. 737 - 740.

43. Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство./Майоров А.Ю. [и др.]. - Москва: ООО "АРТИНФО", 2018. - 64 с.

44. New Insulin Delivery Recommendations/A.H. Frid [et al.]//Mayo Clinic Proceedings. - 2016. - Vol. 91. - N 9. - P. 1231 - 1255.

45. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants/K.M. Miller [et al.]//Diabetes Care. - 2013. - Vol. 36. - N 7. - P. 2009 - 2014.

46. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes/R. Ziegler [et al.]//Pediatric Diabetes. - 2011. - Vol. 12. - N 1. - P. 11 - 17.

47. 20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes/B. Bohn [et al.]//PloS One. - 2016. - Vol. 11. - N 8. - P. e0160971.

48. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial/T. Battelino [et al.]//Diabetologia. - 2012. - Vol. 55. - N 12. - P. 3155 - 3162.

49. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring/A.H. El-Laboudi [et al.]//Diabetes Technology & Therapeutics. - 2016. - Vol. 18. - N 12. - P. 806 - 812.

50. Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase/R.M. Bergenstal [et al.]//Diabetes Care. - 2011. - Vol. 34. - N 11. - P. 2403 - 2405.

51. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents/H. Phelan [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 75 - 83.

52. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials/K. Winkley [et al.]//BMJ (Clinical research ed.). - 2006. - Vol. 333. - N 7558. - P. 65.

53. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review/S.E. Hampson [et al.]//Health Technology Assessment (Winchester, England). - 2001. - Vol. 5. - N 10. - P. 1 - 79.

DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial/DAFNE Study Group//Diabetic Medicine: A Journal of the British Diabetic Association. - 2003. - Vol. 20 Suppl 3. - P. 4 - 5.

55. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials/E. [et al.]//Pediatric Diabetes. - 2009. - Vol. 10. - N 1. - P. 52 - 58.

56. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis/K. Benkhadra [et al.]//Endocrine. - 2017. - Vol. 55. - N 1. - P. 77 - 84.

Pickup, J.C. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion/J.C. Pickup, A.J. Sutton//Diabetic medicine: a journal of the British Diabetic Association. - 2008. - Vol. 25. - N 7. - P. 765 - 774.

58. The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes/M.D.R. Vallejo-Mora [et al.]//Journal of Diabetes. - 2017. - Vol. 9. - N 1. - P. 24 - 33.

59. Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)/M.D.R. Vallejo Mora [et al.]//Diabetes Technology & Therapeutics. - 2017. - Vol. 19. - N 7. - P. 402 - 409.

60. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial/R. Ziegler [et al.]//Diabetes Care. - 2013. - Vol. 36. - N 11. - P. 3613 - 3619.

61. Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study/S. Schmidt [et al.]//Diabetes Care. - 2012. - Vol. 35. - N 5. - P. 984 - 990.

62. The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review/A. Ramotowska [et al.]//Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association. - 2013. - Vol. 121. - N 5. - P. 248 - 254.

63. A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data/J.C. Wong [et al.]//Diabetes Technology & Therapeutics. - 2015. - Vol. 17. - N 8. - P. 555 - 562.

64. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study/R.H. Slover [et al.]//Pediatric Diabetes. - 2012. - Vol. 13. - N 1. - P. 6 - 11.

65. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial/T.T. Ly [et al.]//JAMA. - 2013. - Vol. 310. - N 12. - P. 1240 - 1247.

66. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes/M.B. Abraham [et al.]//Diabetes Care. - 2018. - Vol. 41. - N 2. - P. 303 - 310.

67. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial/T. Battelino [et al.]//Diabetes Care. - 2017. - Vol. 40. - N 6. - P. 764 - 770.

68. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies/J.L. Sherr [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 302 - 325.

69. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents/H. Phelan [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 75 - 83.

M. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT/M., E. //Pediatric Diabetes. - 2012. - Vol. 13. - N 7. - P. 534 - 539.

71. Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes/T. Battelino [et al.]//Diabetes Care. - 2011. - Vol. 34. - N 4. - P. 795 - 800.

Pickup, J.C. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data/J.C. Pickup, S.C. Freeman, A.J. Sutton//BMJ (Clinical research ed.). - 2011. - Vol. 343. - P. d3805.

73. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study/I.B. Hirsch [et al.]//Diabetes Technology & Therapeutics. - 2008. - Vol. 10. - N 5. - P. 377 - 383.

74. Use of the GlucoWatch biographer in children with type 1 diabetes/H.P. Chase [et al.]//Pediatrics. - 2003. - Vol. 111. - N 4 Pt 1. - P. 790 - 794.

75. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects/F.R. Kaufman [et al.]//Diabetes Care. - 2001. - Vol. 24. - N 12. - P. 2030 - 2034.

Ludvigsson, J. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study/J. Ludvigsson, R. Hanas//Pediatrics. - 2003. - Vol. 111. - N 5 Pt 1. - P. 933 - 938.

77. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes/C.E. Smart [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 136 - 154.

78. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus/J.I. Mann [et al.]//Nutrition, metabolism, and cardiovascular diseases: NMCD. - 2004. - Vol. 14. - N 6. - P. 373 - 394.

79. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial/L.M. Delahanty [et al.]//The American Journal of Clinical Nutrition. - 2009. - Vol. 89. - N 2. - P. 518 - 524.

80. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era/K.J. Bell [et al.]//Diabetes Care. - 2015. - Vol. 38. - N 6. - P. 1008 - 1015.

Nansel, T.R. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes/T.R. Nansel, L.M. Lipsky, A. Liu//The American Journal of Clinical Nutrition. - 2016. - Vol. 104. - N 1. - P. 81 - 87.

82. Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with Type 1 diabetes mellitus/M.A. Paterson [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. - 2017. - Vol. 34. - N 6. - P. 851 - 854.

83. Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive/C.E.M. Smart [et al.]//Diabetes Care. - 2013. - Vol. 36. - N 12. - P. 3897 - 3902.

84., E. Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study/E., M., L. Groele//Diabetes Technology & Therapeutics. - 2012. - Vol. 14. - N 1. - P. 16 - 22.

85. Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach: Hvidoere group studies/F. Cameron [et al.]//Pediatric Diabetes. - 2013. - Vol. 14. - N 7. - P. 473 - 480.

86. Physical activity interventions in children and young people with Type 1 diabetes mellitus: a systematic review with meta-analysis/H. Quirk [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. - 2014. - Vol. 31. - N 10. - P. 1163 - 1173.

87. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy/F. MacMillan [et al.]//Pediatric Diabetes. - 2014. - Vol. 15. - N 3. - P. 175 - 189.

88. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis/M. Nocon [et al.]//European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - 2008. - Vol. 15. - N 3. - P. 239 - 246.

Riddell, M.C. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management/M.C. Riddell, B.A. Perkins//Canadian Journal of Diabetes. - 2006. - Vol. 30. - N 1. - P. 63 - 71.

90. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes/P. Adolfsson [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 205 - 226.

91. Eating problems in adolescents with Type 1 diabetes: a systematic review with meta-analysis/V. Young [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. - 2013. - Vol. 30. - N 2. - P. 189 - 198.

92. Depression and adherence to treatment in diabetic children and adolescents: a systematic review and meta-analysis of observational studies/C. Kongkaew [et al.]//European Journal of Pediatrics. - 2014. - Vol. 173. - N 2. - P. 203 - 212.

93. ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes/C. Pihoker [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 84 - 104.

94. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006/Y.H. Cho [et al.]//Pediatric Diabetes. - 2011. - Vol. 12. - N 8. - P. 682 - 689.

95. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents/K.C. Donaghue [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 262 - 274.

96. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association/J.L. Chiang [et al.]//Diabetes Care. - 2018. - Vol. 41. - N 9. - P. 2026 - 2044.